en POLSKI
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees

Journal integrated with

integrated with publons
4/2024
vol. 30
 
Share:
Send email
Share:
Original paper

Deficiency of arginine vasopressin in children – diagnostic and therapeutic approaches to improve patients' quality of life based on a 25-year, single-centre retrospective analysis

Dorota Roztoczyńska
1
,
Anna Iwańska
1
,
Anna Wędrychowicz
1
,
Dominika Januś
1
,
Agata Zygmunt-Górska
1
,
Małgorzata Wójcik
1
,
Jerzy Starzyk
1

  1. Department of Pediatric and Adolescent Endocrinology, Chair of Paediatrics, Institute of Paediatrics, Jagiellonian University Medical College, Krakow, Poland
Pediatr Endocrinol Diabetes Metab 2024; 30 (4): 198-210
DOI: https://doi.org/10.5114/pedm.2024.146684
Online publish date: 2025/01/27
Article file
- 0326_Deficiency of arginine.pdf  [4.28 MB]
Get citation
 
PlumX metrics:
 
1. Arima H, Azuma Y. Central diabetes insipidus. Nagoya J Med Sci 2016; 78: 349–358. doi: 10.18999/nagjms.78.4.349.
2. Patti G, Napoli F, Fava D, et al. Approach to the Pediatric Patient: Central Diabetes Insipidus. J Clin Endocrinol Metab 2022; 107: 1407–1416. doi: 10.1210/clinem/dgab930.
3. Angelousi A, Alexandraki KI, Mytareli C, et al. New developments and concepts in the diagnosis and management of diabetes insipidus (AVP-deficiency and resistance). J Neuroendocrinol 2023; 35: e13233. doi: 10.1111/jne.13233.
4. Korkmaz HA, Kapoor RR, Kalitsi J, et al. Central Diabetes Insipidus in Children and Adolescents: Twenty-Six Year Experience from a Single Centre. Int J Endocrinol 2022; 2022: 9397130. doi: 10.1155/2022/9397130.
5. Driano J, Lteif A. Vasopressin-Dependent Disorders: What Is New in Children? Pediatrics 2021; 147: e2020022848. doi: 10.1542/peds.2020-022848.
6. Weiner A, Vuguin P. Diabetes Insipidus. Pediatr Rev 2020; 41: 96–99. doi: 10.1542/pir.2018-0337.
7. Cerbone M, Visser J. Management of children and young people with idiopathic pituitary stalk thickening, central diabetes insipidus, or both: a national clinical practice consensus guideline. Lancet Child Adolesc Health 2021; 5: 662–676. doi: 10.1016/S2352-4642(21)00088-2.
8. Moszczyńska E, Baszyńska-Wilk M. Pituitary stalk thickening in patients under 18 years of age – the most common causes and diagnostic procedures. Pediatr Endocrinol Diabetes Metab 2022; 28: 213–227. doi: 10.5114/pedm.2022.115202.
9. Ji X, Wang Z. Characteristics of Pediatric Patients With Sellar and Suprasellar Lesions Who Initially Present With Central Diabetes Insipidus: A Retrospective Study of 55 Cases From a Large Pituitary Center in China. Front Endocrinol (Lausanne) 2020; 11: 76. doi: 10.3389/fendo.2020.00076.
10. Winzeler B, Cesana-Nigro N. Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study. Lancet 2019; 394: 587–595. doi: 10.1016/S0140-6736(19)31255-3.
11. Binder G, Weber K, Peter A, Schweizer R. Arginine-stimulated copeptin in children and adolescents. Clin Endocrinol (Oxf) 2023; 98: 548–553. doi: 10.1111/cen.14880.
12. Bonnet L, Marquant E, Fromonot J, et al. Copeptin assays in children for the differential diagnosis of polyuria-polydipsia syndrome and reference levels in hospitalized children. Clin Endocrinol (Oxf) 2022; 96: 47–53. doi: 10.1111/cen.14620.
13. Maghnie M, Genovese E, Aricò M, et al. Evolving pituitary hormone deficiency is associated with pituitary vasculopathy: dynamic MR study in children with hypopituitarism, diabetes insipidus, and Langerhans cell histiocytosis. Radiology 1994; 193: 493–499. doi: 10.1148/radiology.193.2.7972767.
14. Adams NC, Farrell TP. Neuroimaging of central diabetes insipidus-when, how and findings. Neuroradiology 2018; 60: 995–1012. doi: 10.1007/s00234-018-2072-7.
15. Shinoda J, Yamada H. Placental alkaline phosphatase as a tumor marker for primary intracranial germinoma. J Neurosurg 1988; 68: 710–720. doi: 10.3171/jns.1988.68.5.0710.
16. Hattab EM, Tu PH. OCT4 immunohistochemistry is superior to placental alkaline phosphatase (PLAP) in the diagnosis of central nervous system germinoma. Am J Surg Pathol 2005; 29: 368–371. doi: 10.1097/01.pas.0000149709.19958.a7.
17. Liu W, Hou J. Causes and Follow-Up of Central Diabetes Insipidus in Children. Int J Endocrinol 2019; 2019: 5303765. doi: 10.1155/2019/5303765.
18. Boguszewski MCS, Boguszewski CL. Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement. Eur J Endocrinol 2022; 186: P35–P52. doi: 10.1530/EJE-21-1186.
19. Lewiński A, Smyczyńska J. National Program of Severe Growth Hormone Deficiency Treatment in Adults and Adolescents after Completion of Growth Promoting Therapy. Endokrynol Pol 2018; 69: 468–524. doi: 10.5603/EP.a2018.0054.
20. Crowley RK, Sherlock M. Clinical insights into adipsic diabetes insipidus: a large case series. Clin Endocrinol (Oxf) 2007; 66: 475–482. doi: 10.1111/j.1365-2265.2007.02754.x.
21. Miljic D, Miljic P. Adipsic diabetes insipidus and venous thromboembolism (VTE): recommendations for addressing its hypercoagulability. Hormones (Athens) 2014; 13: 420–423. doi: 10.14310/horm.2002.1496.
22. Janus DM, Wojcik M. Adipsic diabetes insipidus in pediatric patients. Indian J Pediatr 2014; 81: 1307–1314. doi: 10.1007/s12098-014-1421-8.
23. Pivonello R, Colao A. Impairment of bone status in patients with central diabetes insipidus. J Clin Endocrinol Metab 1998; 83: 2275–2280. doi: 10.1210/jcem.83.7.4987.
24. Wüster C, Abs R. KIMS Study Group and the KIMS International Board. Pharmacia & Upjohn International Metabolic Database. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 2001; 16: 398–405. doi: 10.1359/jbmr.2001.16.2.398.
25. Simm PJ, Biggin A; APEG Bone Mineral Working Group. Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health 2018; 54: 223–233. doi: 10.1111/jpc.13768.

Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.